With no current viable treatments to slow or stop the progression of AD, the findings by Hinrich et al (2016) represent an innovative and promising strategy as they suggest that ASOs might also improve cognition in the aging human brain by shifting the splicing of Apoer2 to include this cytoplasmic insert. Here, LRP8 is linked to Alzheimer disease.